LEBANON. MORE THAN ONE PERSPECTIVE.INDEPENDENT VIEW · AD FREE
lebaneseinsiderTHE BIGGER PICTURE
العربية
Economy

Retatrutide... A weight-loss drug with record results and risks still under study

WhatsApp ↗اقرأ بالعربية
Retatrutide... A weight-loss drug with record results and risks still under study
Lebanon 24
WHAT TO KNOW

Lebanon 24: The weight-loss drug sector has been witnessing rapid development since the discovery of the ability of “GLP-1” drugs to achieve notable weight loss. Among injectable drugs, such as “semaglutide” and “tirzepatide,” and ongoing efforts to develop new treatments, the drug “ريتاتروتايد” (Retatrutide) has emerged as one…

Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.

More in Economy

YOUR NEWS, YOUR PACE

Stay in the picture.

Choose the updates that matter to you. No account needed.